System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Judith Passildas is an expert in Oncology at Centre Jean Perrin (France). Judith Passildas has authored 19 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 5 of them ongoing. SLR score: 141 (community average: 125). How the SLR is computed.

LeadR Profile

Judith Passildas Centre Jean Perrin France
141 ScienceLeadR Reputation 141

Unlock

Register Login
Network Map

Oncology

Subspecialties: Public Health - Gynecology - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2018 - 2026
Source: PubMed

Centre Jean Perrin

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 19

Citations

Citations: 123 1st author: 5 Last author: 0 Unique author: 0

Main journals

Cancer Res 3
Clin Breast Cancer 2
Health Sci Rep 2
Aging Clin Exp Res 1
Anticancer Res 1

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Study Protocol for Assessment of the Feasibility of an Intraoperative Localization Technique Using Augmented Reality in Breast-Conserving Surgery for Non-Palpable Cancer Lesions: A Feasibility Study.
PMID 42661930 — feasibility studies, breast neoplasms, augmented reality, neoplasms, breast, wounds and injuries		Health Sci Rep20260
Patient-reported satisfaction with thermal water-based cosmetic products in breast cancer patients undergoing chemotherapy: a feasibility study.
PMID 41812302 — skin, feasibility studies, breast neoplasms, neoplasms, drug therapy, breast, therapeutics, chemotherapy		Cancer Treat Res Commun20260
Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational study.
PMID 40090228 — breast neoplasms, neoplasms, neoplasm metastasis, breast, therapeutics, prognosis		Cancer Epidemiol20250
Post-therapeutic support and rehabilitation for breast cancer women in complete remission in a thermal resort: study protocol for the PACThe Real-Life conditions observational trial.
PMID 39881247 — quality of life, breast neoplasms, health resorts, neoplasms, rehabilitation, breast, therapeutics		BMC Cancer20250
Comparison of the Predictive and Prognostic Capacities of Neutrophil, Lymphocyte and Platelet Counts and Tumor-infiltrating Lymphocytes in Triple-negative Breast Cancer: Preliminary Results of the PERCEPTION Study.
PMID 39477319 — cells, triple negative breast neoplasms, platelet count, blood, breast neoplasms, lymphocytes, lymphocytes, tumor-infiltrating, neoplasms, perception, neutrophils, biopsy, biomarkers, breast, cell count, blood cells, blood platelets, blood cell count		Anticancer Res20240

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 6

By status:

Recruiting 4
Active not recruiting 1
Completed 1

By type:

Interventional 4
Observational 2

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 1
multicentric5to9 1
multicentricup10 1

Main Topics

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Identification of Genetic Phenotypic Clinical Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum based Therapy From Patients Defined as Long term Responders to Platinum based Therapy
NCT07361471 — ovary, neoplasms, ovarian neoplasms, therapeutics		N/ARecruiting2026
Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium PSMA 617 (Lu PSMA) Treatment for Castration resistant Metastatic Prostate Cancer
NCT06600802 — genes, blood, blood specimen collection, neoplasms, prostate, biomarkers, prostatic neoplasms, castration, therapeutics, tissues, dna, men		N/ARecruiting2024
Impact of Implementing the Modified A DIVA Scale on Successful Access to a Venous Line on the First Attempt
NCT06062199 — nurses, chronic disease, pain		N/ARecruiting2024
Support and Post therapeutic Rehabilitation for Women in Complete Remission of Breast Cancer in a Thermal Environment
NCT05433077 — quality of life, breast neoplasms, neoplasms, rehabilitation, breast, therapeutics, environment, carcinoma, women		N/AActive not recruiting2022
Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer
NCT04133077 — serology, blood, breast neoplasms, neoplasms, breast, neoadjuvant therapy, therapeutics, heterografts, prospective studies, female		N/ARecruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS